Side Menu

• About Novalar 
• CEO Welcome Letter 
• Leadership Team 
• Board of Directors 
• Clinical Advisory Board 
• Corporate Events 

Static Side Menu

• Careers 
• Contact Us 
• Home 

Clinical Advisory Board

Novalar's Clinical Advisory Board for OraVerse^® (phentolamine mesylate) consists of leaders in the fields of dental anesthesiology, pharmacology, and dentistry. The Advisory Board lends its knowledge and expertise to our clinical and product development teams.

Paul Stevens Casamassimo, BS, DDS, MS
The Ohio State University College of Dentistry

Elliott V. Hersh, DMD, MS, PhD
University of Pennsylvania School of Dental Medicine

Stanley Malamed, DDS
University of Southern California School of Dentistry

Paul Moore, DMD, PhD, MPH
University of Pittsburgh School of Dental Medicine

Athena Papas, DMD, PhD
Tufts University School of Dental Medicine

Bruce Rutherford, DDS, PhD
University of Washington School of Dentistry

Deborah Studen-Pavlovich, BS, DMD
University of Pittsburg School of Dental Medicine

Mary Tavares, DMD, MPH
The Forsyth Institute

John A. Yagiela, DDS, PhD
UCLA School of Dentistry